PYRIDOXINE HYDROCHLORIDE- pyridoxine hydrochloride tablet 
VersaPharm Incorporated

----------


Pyridoxine Hydrochloride Tablets USP, 25 mg (Vitamin B6)

Supplement Facts

​                                                       Serving Size: 1 Tablet
Amount Per Tablet  % Daily Value
 Vitamin B6 25 mg (as Pyridoxine Hydrochloride)                     1250 %
 Other ingredients: Dicalcium Phosphate, Microcrystalline Cellulose, Stearic Acid, Magnesium Stearate and Silicon Dioxide.

Suggested Use

As a dietary supplement for adults, take one tablet daily with a full glass of water, preferably after a meal.

Keep out of reach of children.

Other Information

Store in a cool, dry place, tightly closed.

Package/Label Principal Display Panel - Bottle Label 25 mg

NDC 61748-092-30

PYRIDOXINE
SUPPLEMENT25 mg USP
(Vitamin B-6)
30 TABLETS

Package/Label Principal Display Panel - Bottle Label 25 mg
PYRIDOXINE HYDROCHLORIDE 
pyridoxine hydrochloride tablet
Product Information
Product TypeDIETARY SUPPLEMENTItem Code (Source)NHRIC:61748-092
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE25 mg
Inactive Ingredients
Ingredient NameStrength
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: L11K75P92J)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NHRIC:61748-092-3030 in 1 BOTTLE, PLASTIC
2NHRIC:61748-092-01100 in 1 BOTTLE, PLASTIC
3NHRIC:61748-092-101000 in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
DIETARY SUPPLEMENT01/01/200212/31/2011
Supplement Facts
Serving Size : Serving per Container :
Amount Per Serving% Daily Value
color
shape
size (solid drugs)9 mm
imprint
scoring1
Labeler - VersaPharm Incorporated (117696953)

Revised: 3/2022
Document Id: 5ac3a70c-6ab9-4332-87e5-987be09d11d3
Set id: cca3c335-f43c-4053-b757-5ec48cf103c5
Version: 2
Effective Time: 20220311
 
VersaPharm Incorporated